-
1
-
-
0019987623
-
Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion
-
MIZUSHIMA, Y., HAMANO Y., YOKOYAMA K. - Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. - Ann. Rehum. Dis., 41, 263-267, 1982.
-
(1982)
Ann. Rehum. Dis.
, vol.41
, pp. 263-267
-
-
Mizushima, Y.1
Hamano, Y.2
Yokoyama, K.3
-
2
-
-
0030602831
-
Lipid microsphere (lipid emulsions) as a drug carrier, An overview
-
MIZUSHIMA Y. - Lipid microsphere (lipid emulsions) as a drug carrier, An overview. - Adv. Drug Deliv. Rev., 20, 113-115, 1996.
-
(1996)
Adv. Drug Deliv. Rev.
, vol.20
, pp. 113-115
-
-
Mizushima, Y.1
-
3
-
-
0030602826
-
Limethason as a lipid microsphere preparation: An overview
-
YOKOYAMA K., WATANABE M. - Limethason as a lipid microsphere preparation: an overview. - Adv. Drug Deliv. Rev., 20, 195-201, 1996.
-
(1996)
Adv. Drug Deliv. Rev.
, vol.20
, pp. 195-201
-
-
Yokoyama, K.1
Watanabe, M.2
-
4
-
-
0028209170
-
Lipid nano-sphere (LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. IV
-
SEKI J., SASAKI H., DOI M., YOSHIKAWA H., TAKAHASHI Y., YAMANE S., FUKUI H., SONOKE S., YAMAMOTO H., HIROSE M., EZURE Y., ANDO T., USHIMARU K., SUGIYAMA M. - Lipid nano-sphere (LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. IV. - J. Controlled Release, 28, 352-353, 1994.
-
(1994)
J. Controlled Release
, vol.28
, pp. 352-353
-
-
Seki, J.1
Sasaki, H.2
Doi, M.3
Yoshikawa, H.4
Takahashi, Y.5
Yamane, S.6
Fukui, H.7
Sonoke, S.8
Yamamoto, H.9
Hirose, M.10
Ezure, Y.11
Ando, T.12
Ushimaru, K.13
Sugiyama, M.14
-
5
-
-
5644300322
-
-
Drug Carriers. - United States Patent #5,651,991, 1997
-
SUGIYAMA M., OKITA A., SEKI J. - Drug Carriers. - United States Patent #5,651,991, 1997.
-
-
-
Sugiyama, M.1
Okita, A.2
Seki, J.3
-
6
-
-
0141867775
-
A novel delivery system for amphotericin B with lipid nano-sphere (LNS)
-
FUKUI H., KOIKE T., SAHEKI A., SONOKE S., SEKI J. - A novel delivery system for amphotericin B with lipid nano-sphere (LNS). - Int. J. Pharm., 265, 37-45, 2003.
-
(2003)
Int. J. Pharm
, vol.265
, pp. 37-45
-
-
Fukui, H.1
Koike, T.2
Saheki, A.3
Sonoke, S.4
Seki, J.5
-
7
-
-
0042383358
-
Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS)
-
FUKUI H., KOIKE T., SAHEKI A., SONOKE S., TOMII Y., SEKI J. - Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS). - Int. J. Pharm., 263, 51-60, 2003.
-
(2003)
Int. J. Pharm.
, vol.263
, pp. 51-60
-
-
Fukui, H.1
Koike, T.2
Saheki, A.3
Sonoke, S.4
Tomii, Y.5
Seki, J.6
-
8
-
-
0242361226
-
Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere(LNS), with commercial lipid-based formulations
-
FUKUI H., KOIKET., NAKAGAWA T., SAHEKI A., SONOKE S., TOMII Y., SEKI J. - Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere(LNS), with commercial lipid-based formulations. - Int. J. Pharm., 267, 101-112, 2003.
-
(2003)
Int. J. Pharm.
, vol.267
, pp. 101-112
-
-
Fukui, H.1
Koiket2
Nakagawa, T.3
Saheki, A.4
Sonoke, S.5
Tomii, Y.6
Seki, J.7
-
9
-
-
1542298888
-
A nanometer lipid emulsion, Lipid Nano-Sphere (LNS), as a parenteral drug carrier for passive drug targeting
-
SEKI J., SONOKE S., SAHEKI A., FUKUI H., SASAKI H., MAYUMI T. - A nanometer lipid emulsion, Lipid Nano-Sphere (LNS), as a parenteral drug carrier for passive drug targeting. - Int. J. Pharm., 273, 75-83, 2004.
-
(2004)
Int. J. Pharm.
, vol.273
, pp. 75-83
-
-
Seki, J.1
Sonoke, S.2
Saheki, A.3
Fukui, H.4
Sasaki, H.5
Mayumi, T.6
-
10
-
-
0035946617
-
Recombinant lipoproteins: Lipoprotein-like lipid particles for drug targeting
-
RENSEN P.C.N., de VRUEH R.L.A., KUIPER J., BIJSTERBOSCH M.K., BIESSEN E.A.L., van BERKEL T.J.C. - Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. - Adv. Drug Deliv. Rev., 47, 251-276, 2001.
-
(2001)
Adv. Drug Deliv. Rev.
, vol.47
, pp. 251-276
-
-
Rensen, P.C.N.1
De Vrueh, R.L.A.2
Kuiper, J.3
Bijsterbosch, M.K.4
Biessen, E.A.L.5
Van Berkel, T.J.C.6
-
11
-
-
0031901271
-
Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs
-
WASAN K.M., CASSIDY S.M. - Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. - J. Pharm. Sci., 87, 411-424, 1998.
-
(1998)
J. Pharm. Sci.
, vol.87
, pp. 411-424
-
-
Wasan, K.M.1
Cassidy, S.M.2
-
12
-
-
5644292961
-
-
Lyophilized fatty emulsions and a process for the production thereof. - United States Patent #5,635,491, 1997
-
SEKI J., YAMAMOTO H., YAMANE S., TAKAHASHI Y., USHIMARU K. - Lyophilized fatty emulsions and a process for the production thereof. - United States Patent #5,635,491, 1997.
-
-
-
Seki, J.1
Yamamoto, H.2
Yamane, S.3
Takahashi, Y.4
Ushimaru, K.5
-
13
-
-
0024299370
-
Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
-
MAHLEY R.W. - Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. - Science, 240, 622-630, 1968.
-
(1968)
Science
, vol.240
, pp. 622-630
-
-
Mahley, R.W.1
-
14
-
-
0024449363
-
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein
-
BEISIEGEL U., WEBER W., IHRKE G., HERZ J., STANLEY K.K. - The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. - Nature, 341, 162-164, 1989.
-
(1989)
Nature
, vol.341
, pp. 162-164
-
-
Beisiegel, U.1
Weber, W.2
Ihrke, G.3
Herz, J.4
Stanley, K.K.5
-
15
-
-
0019802775
-
Effect of core composition and particle size of lipid emulsions on apolipoprotein transfer of plasma lipoproteins in vivo
-
CONNELLY P.W., KUKSIS A. - Effect of core composition and particle size of lipid emulsions on apolipoprotein transfer of plasma lipoproteins in vivo. - Biochim. Biophys. Acta, 666, 80-89, 1981.
-
(1981)
Biochim. Biophys. Acta
, vol.666
, pp. 80-89
-
-
Connelly, P.W.1
Kuksis, A.2
-
16
-
-
0035021487
-
Stability and plasma apolipoprotein binding of lipid emulsions
-
HANDA T. - Stability and plasma apolipoprotein binding of lipid emulsions. - Food Hydrocolloids, 15, 277-283, 2001.
-
(2001)
Food Hydrocolloids
, vol.15
, pp. 277-283
-
-
Handa, T.1
-
17
-
-
2942737329
-
Decreased binding affinity of apolipoprotein e plays an important role in the reduced hepatic clearance of Lipid Nano-Sphere (LNS)
-
SEKI J., SONOKE S., SAHEKI A., FUKUI H., MAYUMI T. - Decreased binding affinity of apolipoprotein E plays an important role in the reduced hepatic clearance of Lipid Nano-Sphere (LNS). - J. Drug Del. Sci. Tech., 14 (3), 173-179, 2004.
-
(2004)
J. Drug Del. Sci. Tech.
, vol.14
, Issue.3
, pp. 173-179
-
-
Seki, J.1
Sonoke, S.2
Saheki, A.3
Fukui, H.4
Mayumi, T.5
-
18
-
-
0037450958
-
Effects of sphingomyelin on apolipoprotein E-and lipoprotein lipase-mediated cell uptake of lipid particles
-
MORITA S., OKUHIRA K., TSUCHIMOTO N., VERTUT-DOÏ A., SAITO H., NAKANO M., HANDA T. - Effects of sphingomyelin on apolipoprotein E-and lipoprotein lipase-mediated cell uptake of lipid particles. - Biochim. Biophys. Acta, 1631, 169-176, 2003.
-
(2003)
Biochim. Biophys. Acta
, vol.1631
, pp. 169-176
-
-
Morita, S.1
Okuhira, K.2
Tsuchimoto, N.3
Vertut-Doï, A.4
Saito, H.5
Nakano, M.6
Handa, T.7
-
19
-
-
0031839172
-
Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions
-
ARIMOTO I., MATSUMOTO C., TANAKA M., OKUHIRA K., SAITO H., HANDA T. - Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions. - Lipids, 33, 773-779, 1998.
-
(1998)
Lipids
, vol.33
, pp. 773-779
-
-
Arimoto, I.1
Matsumoto, C.2
Tanaka, M.3
Okuhira, K.4
Saito, H.5
Handa, T.6
-
20
-
-
0038356305
-
Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions
-
YAMAMOTO M., MORITA S., KUMON M., KAWABE M., NISHITSUJI K., SAITO H., VERTUT-DOÏ A., NAKANO M., HANDA T. - Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions. - Biochim. Biophys. Acta, 1632, 31-39, 2003.
-
(2003)
Biochim. Biophys. Acta
, vol.1632
, pp. 31-39
-
-
Yamamoto, M.1
Morita, S.2
Kumon, M.3
Kawabe, M.4
Nishitsuji, K.5
Saito, H.6
Vertut-Doï, A.7
Nakano, M.8
Handa, T.9
-
21
-
-
0029760637
-
The metabolic distinctiveness of emulsified lipid particles in the bloodstream and its clinical implications
-
IRIYAMA K. - The metabolic distinctiveness of emulsified lipid particles in the bloodstream and its clinical implications. - Surg. Today, 26, 673-678, 1996.
-
(1996)
Surg. Today
, vol.26
, pp. 673-678
-
-
Iriyama, K.1
-
22
-
-
0023832675
-
Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles
-
IRIYAMA K., NISHIWAKI H., TERASHIMA H., TONOUCHI H., MIKI C., SUZUKI H., CARPENTIER Y. A. - Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles. - J.P.E.N., 12, 60-62, 1987.
-
(1987)
J.P.E.N.
, vol.12
, pp. 60-62
-
-
Iriyama, K.1
Nishiwaki, H.2
Terashima, H.3
Tonouchi, H.4
Miki, C.5
Suzuki, H.6
Carpentier, Y.A.7
-
23
-
-
0034952962
-
Interaction between erythrocytes from three different animals and emulsions prepared with various lecithins and oils
-
NAGASAKA Y., ISHII F. - Interaction between erythrocytes from three different animals and emulsions prepared with various lecithins and oils. - Colloids and Surfaces B: Biointerfaces, 22, 141-147, 2001.
-
(2001)
Colloids and Surfaces B: Biointerfaces
, vol.22
, pp. 141-147
-
-
Nagasaka, Y.1
Ishii, F.2
-
24
-
-
0034672281
-
Lecithin cholesterol acyltransferase
-
JONAS A. - Lecithin cholesterol acyltransferase. - Biochim. Biophys. Acta, 1529, 245-256, 2000.
-
(2000)
Biochim. Biophys. Acta
, vol.1529
, pp. 245-256
-
-
Jonas, A.1
-
25
-
-
0141703401
-
An assessment of techniques for evaluating the physical stability of parenteral emulsions
-
ZHANG X., KIRSCH L.E. - An assessment of techniques for evaluating the physical stability of parenteral emulsions. - PDA J. Pharm. Sci. Tech., 57, 300-315, 2003.
-
(2003)
PDA J. Pharm. Sci. Tech.
, vol.57
, pp. 300-315
-
-
Zhang, X.1
Kirsch, L.E.2
-
26
-
-
0029134080
-
Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway
-
KARPE F., HULTIN M. - Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. - J. Lipid Res., 36, 1557-1566, 1995.
-
(1995)
J. Lipid Res.
, vol.36
, pp. 1557-1566
-
-
Karpe, F.1
Hultin, M.2
-
27
-
-
0023897784
-
Characteristics of chylomicron remnant uptake into rat liver
-
HUETTINGER M., RETZEK H., EDER M., GOLDENBERG H. - Characteristics of chylomicron remnant uptake into rat liver. - Clin. Biochem., 21, 87-92, 1988.
-
(1988)
Clin. Biochem.
, vol.21
, pp. 87-92
-
-
Huettinger, M.1
Retzek, H.2
Eder, M.3
Goldenberg, H.4
-
28
-
-
0025990629
-
Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha-2-macroglobulin-recognition site
-
van DIJK M.C.M., ZIERE G.J., BOERS W.B., LINTHORST C., BIJSTERBOSCH M.K. - Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha-2-macroglobulin-recognition site. - Biochem. J., 279, 863-870, 1991.
-
(1991)
Biochem. J.
, vol.279
, pp. 863-870
-
-
Van Dijk, M.C.M.1
Ziere, G.J.2
Boers, W.B.3
Linthorst, C.4
Bijsterbosch, M.K.5
-
29
-
-
0033729638
-
Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism
-
MEDH J.D., FRY G.L., BOWEN S.L., RUBEN S., WONG H., CHAPPEL D.A. - Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism. - J. Lipid. Res., 41, 1858-1871, 2000.
-
(2000)
J. Lipid. Res.
, vol.41
, pp. 1858-1871
-
-
Medh, J.D.1
Fry, G.L.2
Bowen, S.L.3
Ruben, S.4
Wong, H.5
Chappel, D.A.6
-
30
-
-
0028224099
-
Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes
-
HARASHIMA H., SAKATA K., FUNATO K., KIWADA H. - Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. - Pharm. Res., 11, 402-406, 1994.
-
(1994)
Pharm. Res.
, vol.11
, pp. 402-406
-
-
Harashima, H.1
Sakata, K.2
Funato, K.3
Kiwada, H.4
-
31
-
-
0019886660
-
Uptake and degradation of rat chylomicron nemnants, produced in vivo and in vitro, in rayt hepatocyte monolaylers
-
NILSSON A., EHNHOLM C., FLOREN C.H. - Uptake and degradation of rat chylomicron nemnants, produced in vivo and in vitro, in rayt hepatocyte monolaylers. - Biochim. Biophys. Acta, 633, 408-420, 1981.
-
(1981)
Biochim. Biophys. Acta
, vol.633
, pp. 408-420
-
-
Nilsson, A.1
Ehnholm, C.2
Floren, C.H.3
-
32
-
-
0035798681
-
Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles
-
SAITO H., DHANASEKARAN P., BALDWIN F., WEISGRABER K.H., LUND-KATZ S., PHILIPS M.C. - Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles. - J. Biol. Chem., 276, 40949-40954, 2001.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 40949-40954
-
-
Saito, H.1
Dhanasekaran, P.2
Baldwin, F.3
Weisgraber, K.H.4
Lund-Katz, S.5
Philips, M.C.6
|